Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with ...

"In a technology-driven climate, effort should be made to recognize that receiving buprenorphine prescriptions from a ...

GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...

Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance. The ...

THE NHS is set to dish out Mounjaro prescriptions to more patients, as private clinics prepare to double their prices from ...

Sprouts opened its third store Friday, Aug. 22, at 110 E. 36th St. in NoDa, helping add to the sparse grocery options in the neighborhood. A small grocer, Southland Supermarket, is near One NoDa, and ...

Hims & Hers is a top telehealth stock with strong revenue growth, innovative offerings, and long-term potential. Click here to read an analysis of HIMS stock now.

It's hard to read the news right now without another article about Ozempic popping up. The fat loss jab - originally ...

With three new antibiotics set to shake up the stagnant treatment landscape for uncomplicated urinary tract infections (uUTIs ...

In today’s edition, we have a deep dive into Sen. Josh Hawley’s effort to stake out ground for himself in the modern ...

The more than $36 million center is hoped to be a “buffer” against supply chain disruptions and improve oversight, said a St. Luke’s executive.